 Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.Biotech stocks went on a roller coaster ride in the week ended March 20 amid the market-wide COVID-19 sell-off. Activity remained light amid the cancellation of many medical meetings.The COVID-19 treatment and vaccine development news flow was front and center, as biopharma and diagnostics companies scrambled to capitalize on the need presented by the pandemic.This news flow is likely to continue into the unfolding week, with companies already in the fray providing updates and new entrants making announcements.View more earnings on IBBRelated Link: 8 Biotechs With Coronavirus Vaccines In DevelopmentThe following are other catalysts that could move stocks in the biotech space: PDUFA Dates The FDA is scheduled to announced its verdict on Bristol-Myers Squibb Cos NYSE: BMY NDA for ozanimod as a treatment option for patients with relapsing forms of multiple sclerosis. WednesdayIntelGenx Technologies Corp. OTCMKTS: IGXTs NDA for rizaport versafilm for the treatment of acute migraine is pending before the FDA, with the target action day fixed for Thursday. The company has faced three rejections for the investigational drug in the past.The FDA is also expected to rule on Rockwell Medical Incs NASDAQ: RMTI sNDA for intravenous formulation of anemia drug Triferic. SaturdayEarnings Monday DiaMedica Therapeutics Inc NASDAQ: DMAC after the close Tuesday Thermogenesis Holdings Inc NASDAQ: THMO after the close OpGen Inc NASDAQ: OPGN after the close Onconova Therapeutics Inc NASDAQ: ONTX after the closeWednesday Viela Bio Inc NASDAQ: VIE after the close Biocept Inc NASDAQ: BIOC after the close OncoCyte Corp NYSE: OCX after the close HTG Molecular Diagnostics Inc NASDAQ: HTGM after the close Eyenovia Inc NASDAQ: EYEN after the close Exagen Inc NASDAQ: XGN after the closeThursday Celsion Corporation NASDAQ: CLSN before the market open Entera Bio Ltd NASDAQ: ENTX before the market open TFF Pharmaceuticals Inc NASDAQ: TFFP before the market open IGM Biosciences Inc NASDAQ: IGMS after the close NovaBay Pharmaceuticals, Inc. NYSE: NBY after the close Vermillion, Inc. NASDAQ: VRML after the closeFriday TELA Bio Inc NASDAQ: TELA before the market open Zyla Life Sciences OTC: ZCOR before the market openIPO Quiet Period Expiry Passage Bio Inc NASDAQ: PASGSee more from Benzinga The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company The Daily Biotech Pulse: Pfizers Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadics COVID-19 ConnectionC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 